VIR
Vir Biotechnology Inc.
Latest News for VIR
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Vir Biotechnology yesterday and set a price target of $15.00. According to TipR......
Kepler Capital analyst Kevin Roger maintained a Buy rating on Viridien on November 19 and set a price target of €160.00. The company’s shares close......
In a report released on November 13, Kevin Roger from Kepler Capital maintained a Buy rating on Viridien, with a price target of €160.00. The compa......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tenax Therapeutics (TENX – Research Report) and Atea......
Barclays analyst Gena Wang maintained a Buy rating on Vir Biotechnology yesterday and set a price target of $31.00. The company’s shares closed yes......
TD Cowen analyst Phil Nadeau maintained a Buy rating on Vir Biotechnology yesterday. The company’s shares closed yesterday at $5.37. According to T......
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Vir Biotechnology on November 3 and set a price target of $15.00. According to ......
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Vir Biotechnology, with a price target of $15.00. Acco......
Virbac SA received a Buy rating and a €415.00 price target from Kepler Capital analyst Christophe dombu on October 31. The company’s shares closed ......
Kepler Capital analyst Kevin Roger maintained a Buy rating on Viridien on October 31 and set a price target of €105.00. The company’s shares closed......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 18 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VIR | $5.74 | +3.1% | 626.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |